Preclinical results for anti-HER2 TLR8 agonist conjugate for the treatment of HER2-expressing tumors April 5, 2019
Phase I results of highly selective dual IDO1/TDO2 inhibitor M-4112 in advanced solid malignancies April 4, 2019
Comparison of the novel biguanide NT-1195 with metformin/phenformin in endometrial cancer models April 4, 2019
Preclinical results of EI-1071, a selective CSF1R inhibitor regulating tumor-associated macrophages April 4, 2019
RSS